News | August 30, 2023
Mankind Pharma launches 120 premium DMF quality drugs for Indian Patients
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
Uses a simple mechanical approach for removing intrauterine tissues
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Good momentum in commercial CDMO business
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
Subscribe To Our Newsletter & Stay Updated
